These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9324602)

  • 1. [Plausible pharmacologic interaction between fosinopril and acenocoumarol].
    de Tomás ME; Sáez L; Beltrán S; Gato A
    Med Clin (Barc); 1997 May; 108(19):757. PubMed ID: 9324602
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction between cyclosporine and acenocoumarol in a patient with nephrotic syndrome.
    Borrás-Blasco J; Enriquez R; Navarro-Ruiz A; Martinez-Ramirez M; Cabezuelo JB; Gonzalez-Delgado M
    Clin Nephrol; 2001 Apr; 55(4):338-40. PubMed ID: 11334326
    [No Abstract]   [Full Text] [Related]  

  • 3. Acenocoumarol and 6-mercaptopurine: an important drug interaction.
    Fernández MA; Regadera A; Aznar J
    Haematologica; 1999 Jul; 84(7):664-5. PubMed ID: 10406922
    [No Abstract]   [Full Text] [Related]  

  • 4. Fosinopril H(2)-receptor antagonists interaction studies by derivative spectroscopy.
    Sultana N; Arayne MS; Sana A
    Pak J Pharm Sci; 2007 Jan; 20(1):19-25. PubMed ID: 17337423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug of the month. fosinopril (Fosinil)].
    Scheen AJ
    Rev Med Liege; 1994 Dec; 49(12):693-4. PubMed ID: 7817060
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of fosinopril treatment on serum C-reactive protein levels in patients with microalbuminuria.
    van der Harst P; Asselbergs FW; Hillege HL; Voors AA; van Veldhuisen DJ; van Gilst WH;
    Am J Cardiol; 2008 Jul; 102(2):223-5. PubMed ID: 18602526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of the drug-drug interaction of acenocoumarol-miconazole.
    Lozano R; Frutos A
    Int J Clin Pharmacol Ther; 2018 Jan; 56(1):28-30. PubMed ID: 29162215
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of a low-dose regimen of fosinopril on elevated urinary albumin excretion in normotensive type 1 diabetic patients.
    Carella MJ; Gossain VV; Jones J
    J Med; 1999; 30(5-6):305-20. PubMed ID: 10851564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of collagen expression of pulmonary arteries and heart ventricles and intervention of fosinopril and losartan in rats with heart failure].
    Wu ZJ; He JG; Li L; Li YH; Cheng XS; Ruan YM; Liu GZ
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):2015-7. PubMed ID: 15730820
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation of acenocoumarol during vaginal administration of miconazole.
    Lansdorp D; Bressers HP; Dekens-Konter JA; Meyboom RH
    Br J Clin Pharmacol; 1999 Feb; 47(2):225-6. PubMed ID: 10190660
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of valsartan and fosinopril on catecholamine-induced cardiac hypertrophy.
    Xiang Y; Huang J
    Acta Pharmacol Sin; 2000 Sep; 21(9):850-4. PubMed ID: 11501170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid.
    Delavenne X; Laporte S; Demasles S; Mallouk N; Basset T; Tod M; Girard P; Mismetti P
    Fundam Clin Pharmacol; 2009 Feb; 23(1):127-35. PubMed ID: 19267776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosinopril prevents the pulmonary arterial remodeling in sinoaortic-denervated rats by regulating phosphodiesterase.
    Tao X; Zhang YJ; Shen FM; Guan YF; Su DF
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):24-31. PubMed ID: 18209565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril.
    Zhang W; Chen X; Shi S; Wei R; Wang J; Yamanaka N; Hong Q
    Nephrol Dial Transplant; 2005 May; 20(5):892-901. PubMed ID: 15755760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
    Asselbergs FW; Diercks GF; Hillege HL; van Boven AJ; Janssen WM; Voors AA; de Zeeuw D; de Jong PE; van Veldhuisen DJ; van Gilst WH;
    Circulation; 2004 Nov; 110(18):2809-16. PubMed ID: 15492322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol.
    Sunkara G; Bigler H; Wang Y; Smith H; Prasad P; McLeod J; Ligueros-Saylan M
    Curr Med Res Opin; 2004 Jan; 20(1):41-8. PubMed ID: 14741071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
    El-Demerdash E; Salam OM; El-Batran SA; Abdallah HM; Shaffie NM
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):159-67. PubMed ID: 17900296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of fosinopril on proteinuria in children with Henoch-Schonlein purpura nephritis].
    Xu J; Cong H; Sheng Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):229-30. PubMed ID: 19292967
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy.
    Lou T; Wang C; Chen Z; Shi C; Tang H; Liu X; Yin P; Yu X
    Nephrology (Carlton); 2006 Apr; 11(2):113-6. PubMed ID: 16669971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Absence of interaction between oral anticoagulants and influenza vaccine].
    Souto JC; Garí M; Borrell M; Fontcuberta J
    Med Clin (Barc); 1993 Nov; 101(16):637. PubMed ID: 8271869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.